ReviewPharmaceutics2026
Beyond Antibiotics: The Role of Antimicrobial Polymers in Modern Therapeutics.
Review in Pharmaceutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobial polymers are a potential and viable alternative to antibiotic therapies, whose effectiveness is increasingly compromised by the onset of antimicrobial resistance and antibiotic persistence. Antimicrobial polymers also have potential in the formulation of new drug delivery systems. Difficulties in finding new naturally derived compounds and classes of antimicrobials pose a major threat to public health and have made finding an alternative crucial. The aim of this review is to provide a comprehensive overview of the antimicrobial polymers currently available, whether of natural or synthetic origin, and to explore their use in pharmaceutical formulations, including a brief description of their preparation methods. Furthermore, a critical assessment of the advantages, limitations, and potential future developments of these systems will be presented, with particular attention to their clinical applicability, safety profiles, and role in combating antimicrobial resistance. Finally, the review highlights key challenges and future directions for the clinical translation of antimicrobial polymer-based systems, with a focus on safety, scalability, and their potential role in addressing antimicrobial resistance.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.